Hydrogen peroxide in exhaled breath condensate in asthmatic children during acute exacerbation and after treatment

Carlo Caffarelli1, Elena Calcinai, Laura Rinaldi

  • 1UO Clinica Pediatrica, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Parma, Via Gramsci 14 IT-43100 Parma, Italy. carlo.caffarelli@unipr.it

Insights

Children with asthma exacerbation have elevated hydrogen peroxide (H(2)O(2)) in exhaled breath condensate (EBC). Treatment did not significantly alter these H(2)O(2) levels or correlate with lung function improvements.

Area of Science:

  • Pediatric Pulmonology
  • Biochemistry of Respiratory Diseases
  • Biomarkers of Airway Inflammation

Background:

  • Elevated hydrogen peroxide (H(2)O(2)) in exhaled breath condensate (EBC) is observed in asthmatic individuals.
  • H(2)O(2) levels in EBC correlate with airway inflammation in asthma.

Purpose of the Study:

  • To investigate if H(2)O(2) levels in EBC of children with acute asthma exacerbation are affected by treatment.
  • To determine the relationship between exhaled H(2)O(2) and airway obstruction in pediatric asthma patients.

Main Methods:

  • Compared EBC H(2)O(2) concentrations in 22 asthmatic children and 12 healthy controls before and after asthma treatment.
  • Utilized spirometry and skin prick tests in asthmatic children and controls.
  • Assessed clinical observations alongside H(2)O(2) measurements.

Main Results:

  • Exhaled H(2)O(2) was significantly higher in asthmatic children versus controls, both before and after treatment.
  • Post-treatment H(2)O(2) levels remained elevated in asthmatic children, irrespective of wheezing presence.
  • No significant correlation was found between EBC H(2)O(2) and forced expiratory volume in 1 second (FEV1).

Conclusions:

  • Children with acute asthma exacerbation exhibit significantly elevated EBC H(2)O(2) levels.
  • Short-term follow-up shows persistent high H(2)O(2) levels post-treatment.
  • Exhaled H(2)O(2) does not appear to correlate with lung function or symptom improvement in the short term.
Abstract

Related Concept Videos

Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...